Dr. Bishnoi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6901 Simmons Loop FL 2
Riverview, FL 33578Phone+1 813-302-8718Fax+1 813-605-6021
Summary
- Dr. Rohit Bishnoi is a physician in Gainesville, FL and is affiliated with UF Health Shands Hospital. He received his medical degree from Sardar Patel Medical College and has been in practice 14 years. He is currently doing fellowship in hematology oncology.
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 2018 - 2021
- McLaren Health Care/Flint/MSUResidency, Internal Medicine, 2007 - 2010
- Sardar Patel Medical CollegeClass of 2003
Certifications & Licensure
- FL State Medical License 2013 - 2026
- GA State Medical License 2021 - 2026
- NC State Medical License 2023 - 2025
- AR State Medical License 2010 - 2018
- MI State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 222 citationsAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy
Annals of Oncology. 2021-06-01 - 3 citationsA Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer.Kelsey Pan, William Paul Skelton, Mohammed Elzeneini, Thu-Cuc Nguyen, Aaron J Franke
Cureus. 2021-04-27 - 4 citationsReduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.Kelsey Pan, Aaron J Franke, William Paul Skelton, Rohit Bishnoi, Chintan Shah
Leukemia & Lymphoma. 2021-04-16
Lectures
- DDP4 inhibitors as novel agents in improving survival in diabetic patients with CRC and lung cancer: A SEER-Medicare study.2019 ASCO Annual Meeting - 6/1/2019
- Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Low Country Cancer Care Opens Clinic in StatesboroJanuary 14th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: